Page last updated: 2024-10-27

fluconazole and Bronchopulmonary Dysplasia

fluconazole has been researched along with Bronchopulmonary Dysplasia in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research Excerpts

ExcerptRelevanceReference
"Bronchopulmonary dysplasia was associated with higher eosinophil counts in the first week of life."1.36Eosinophilia in very low birth weight infants. ( Hou, ST; Lin, AH; Lin, CH; Lin, YJ; Yang, MM; Yen, JM, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yen, JM1
Lin, CH1
Yang, MM1
Hou, ST1
Lin, AH1
Lin, YJ1

Other Studies

1 other study available for fluconazole and Bronchopulmonary Dysplasia

ArticleYear
Eosinophilia in very low birth weight infants.
    Pediatrics and neonatology, 2010, Volume: 51, Issue:2

    Topics: Antifungal Agents; Bronchopulmonary Dysplasia; Eosinophilia; Fluconazole; Humans; Infant, Newborn; I

2010